Brokers name 3 ASX shares to buy today

Brokers are bullish on these ASX shares…

| More on:
ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Ansell Limited (ASX: ANN)

According to a note out of Citi, its analysts have retained their buy rating and increased their price target on this safety products company’s shares to $46.50. The broker has upgraded its earnings estimates to reflect the benefit from COVID lasting longer than previously expected. Citi expects this to ultimately lead to Ansell being in a net cash position by the end of FY 2023. This will then give the company the balance sheet capacity to consider earnings accretive acquisitions or buyback. The Ansell share price was trading at $36.30 at Friday’s close.

BHP Group Ltd (ASX: BHP)

A note out of Macquarie reveals that its analysts have retained their outperform rating and $54.00 price target on this mining giant’s shares. Macquarie has lifted its oil and gas price estimates to reflect a lengthening cycle. The broker expects an average Brent crude oil price of US$66 a barrel over the next 12 months. And while it acknowledges that the company is divesting its oil and gas operations, this is still relevant as shareholders will be given shares in the new entity. The BHP share price ended the week at $41.25.

ResMed Inc. (ASX: RMD)

Analysts at Credit Suisse have retained their outperform rating and lifted their price target on this medical device company’s shares to $44.00. This follows the company’s investor day event earlier this week. The broker notes that management highlighted its strong competitive advantage this year thanks to a significant product recall by rival Philips. The broker was also pleased with its plans to expand patient reach and its new partnership with CVS Health. Credit Suisse expects this to support above industry growth. The ResMed share price was fetching $40.17 at Friday’s close.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended Ansell Ltd. and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes